Peptides  ›  PT-141  ›  Libido
Sexual Health

PT-141 for Libido: What the Research Says

FDA-approved for a specific indication.Updated August 2026

PT-141 (also known as Bremelanotide) is a melanocortin agonist approved for certain forms of low sexual desire. This page covers what the published research does — and does not — establish about it in relation to libido and sexual health.

What the research covers

PT-141 is researched for Libido & sexual arousal, Sexual dysfunction studies — which is why it appears in discussions of libido and sexual health.

Research status: FDA-approved for a specific indication.

How PT-141 is thought to work

PT-141 (bremelanotide) is a melanocortin receptor agonist. Rather than acting on blood flow like vascular treatments, it works on nervous-system pathways involved in sexual arousal, and is FDA-approved for hypoactive sexual desire disorder in certain populations.

What it does not establish

Prescription medication. Can affect blood pressure; medical supervision advised.

Nothing on this page is a recommendation to use PT-141, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.

Other peptides researched for Libido

A hypothalamic peptide studied for its role in reproductive hormone signaling.

A synthetic form of GnRH used to stimulate pituitary hormone release.

A melanocortin agonist studied for skin pigmentation.

Frequently asked questions

FDA-approved for a specific indication. Research relevant to this area covers libido & sexual arousal, sexual dysfunction studies. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.

FDA-approved for a specific indication.

Prescription medication. Can affect blood pressure; medical supervision advised. Always speak to a licensed healthcare professional before considering any peptide.

It is FDA-approved (as bremelanotide) for premenopausal women with hypoactive sexual desire disorder. Other uses are off-label.

It acts centrally on arousal pathways via melanocortin receptors rather than on blood flow, so its mechanism differs from PDE5 inhibitors.

Is PT-141 right for your situation?

Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.

Ask the Advisor — free

This page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.